DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Report
- Report Number
- 1416980-2014-33274
- Event Type
- Injury
- Date Received
- September 25, 2014
- Date of Event
- August 15, 2014
- Report Date
- September 1, 2014
- Manufacturer
- BAXTER HEALTHCARE CORPORATION
- Product Code
- KDI
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TU
- Reporter Occupation
- NURSE
Narratives
(B)(4). (B)(6). THE REPORTED PRODUCT IS AN UNKNOWN BAXTER MINICAP. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. (B)(4).
(B)(4). IT WAS REPORTED THAT A PEDIATRIC PATIENT EXPERIENCED STERILE PERITONITIS COINCIDENT WITH PERITONEAL DIALYSIS THERAPY. THE PATIENT WAS NOT HOSPITALIZED FOR THE EVENT. THE CAUSE OF THE PERITONITIS WAS NOT REPORTED. THE PATIENT WAS TREATED WITH SEFAZOL (ACTIVE SUBSTANCE: CEFAZOLIN SODIUM) (125MG/L TWICE A DAY; ROUTE AND DURATION NOT REPORTED) AND ZIDIM (ACTIVE SUBSTANCE: CEFTAZIDIME) (125MG/L TWICE A DAY; ROUTE AND DURATION NOT REPORTED) FOR PERITONITIS. THERAPY WAS ONGOING. THE PATIENT RECOVERED 18 DAYS AFTER THE ONSET OF THE EVENT. (B)(6). SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
IT WAS REPORTED THAT A PATIENT EXPERIENCED PERITONITIS COINCIDENT WITH PERITONEAL DIALYSIS (PD) THERAPY. THE CAUSE OF THE PERITONITIS WAS UNKNOWN. IT WAS UNKNOWN IF THE PATIENT WAS HOSPITALIZED FOR THE EVENT. TREATMENT AND PATIENT OUTCOME WAS NOT REPORTED. ACTION TAKEN WITH PD THERAPY WAS UNKNOWN. ADDITIONAL INFORMATION WAS REQUESTED BUT IS NOT AVAILABLE. THIS IS REPORT 4 OF 4 INVOLVED IN THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 598303 | DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM | KDI | BAXTER HEALTHCARE CORPORATION |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 16 YR | Other| R | HOMECHOICE| TRANSFER SET, CASSETTE, TITANIUM ADAPTER| DIANEAL PD4 2.27% |